Clik here to view.
画期的な新調査で成人糖尿病患者は不必要な失明リスクを持つことが判明
英ニューベリー （ビジネスワイヤ） — 失明は糖尿病の他の合併症（心血管疾患および脳卒中を含む）の脅威より2倍多いにもかかわらず、調査を受けた糖尿病患者の4分の1は眼合併症について担当の医療専門家と話し合っておらず、多くの患者は視覚障害が生じてから診察を受けています1。これらの問題は、本日発表されたDR Barometer...
View ArticleClik here to view.
ゴアのGlobal Registry for Endovascular Aortic Treatmentが患者組み入れを完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、VEITHsymposium®にて、Global Registry for Endovascular Aortic Treatment...
View ArticleClik here to view.
Last Chance to Fix Failed Rhinoplasty: 3D Procedure – TL Plastic Surgery Korea
SEOUL, South Korea As a facial feature that sits front and center, any bump, misalignment, or other flaw in your nose can dramatically decrease your self-confidence. And because you need your nose...
View ArticleClik here to view.
NTT DATA Services Announces Partnership with AnatomyWorks for Brain Mapping...
CHICAGO NTT DATA Services, formerly Dell Services, today announced its partnership with AnatomyWorks to further enhance analytics tools that will provide greater brain mapping detail and proficiency...
View ArticleClik here to view.
NINLARO™ (ixazomib) Receives Conditional Approval from the European...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission has granted conditional marketing authorization for NINLAROTM...
View ArticleClik here to view.
NTT DATA Services Announces Partnership with Imbio for Lung Analytic...
CHICAGO NTT DATA Services, formerly Dell Services, today announced its partnership with Imbio, which will provide algorithms for lung analytics. The algorithms are designed to further enhance...
View ArticleClik here to view.
COA 2016 in Beijing, China: joimax® Shows Major Presence and Inaugurates New...
IRVINE, Calif. joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, again exhibited at Chinese Orthopedic...
View ArticleClik here to view.
MinInvasive Announces a New Round of Financing and Strategic Partnership with...
MAGAL, Israel MinInvasive Ltd. developer of the OmniCuff™ device for the treatment of rotator cuff repair, announced today the completion of a financing transaction and a strategic partnership with...
View ArticleClik here to view.
Sosei Subsidiaries Heptares to Acquire G7 Therapeutics to Extend Leadership...
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today announces that Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei, has signed a share purchase...
View ArticleClik here to view.
Minomic Announces Completion of Oversubscribed Capital Raising at AGM
SYDNEY Immuno-oncology company, Minomic International Ltd, announced the successful completion of its current funding round at its Annual General Meeting of Shareholders on Tuesday November 29. The...
View ArticleClik here to view.
Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial...
CAMBRIDGE, Mass. & OSAKA, Japan & BOTHELL, Wash. Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ALCANZA...
View ArticleClik here to view.
Dr. Yim of TL Plastic Surgery Successfully Delivered Lecture on...
SEOUL, South Korea PRS (Plastic and Reconstructive Surgeons) KOREA 2016 ‘Motiva Launching Symposium’ was held from 17th to 20th of November 2016. This Smart News Release features multimedia. View...
View ArticleClik here to view.
Solasia Pharma and Meiji Seika Pharma Announce License and Distribution...
TOKYO Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President: Yoshihiro Arai, hereinafter “Solasia”) announced today that Solasia and Meiji Seika Pharma Co. Ltd., (Headquarters: Tokyo, Japan,...
View ArticleClik here to view.
Amano Dental Clinic (Japan) Launches Tooth Brushing App “Brush’n'Save”...
TOKYO Amano Dental Clinic (Director: Kiyoshi Amano) announces that it is now offering Dr. Amano’s originally created brushing app “Brush’n'Save” in an English version to 130 countries and regions...
View ArticleClik here to view.
Listing of Kubota Pharmaceutical Holdings Co., Ltd. and Forecast for Fiscal...
TOKYO Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo: 4596) (the “Company”) hereby gives notice that the merger agreement regarding its proposed redomicile transaction became effective on December...
View ArticleClik here to view.
Chi-Med Presents Pre-clinical Data for Selective Syk Inhibitor HMPL-523 at...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that data from a recent pre-clinical study, investigating the in vitro and in vivo anti-tumor activities of...
View ArticleClik here to view.
Amano Dental Clinic（日本）推出由一线牙医开发的刷牙应用“Brush’n'Save”，旨在让女儿远离龋齿
东京 (美国商业资讯)–Amano Dental Clinic（董事：Kiyoshi Amano）宣布，Amano医生的原创刷牙应用“Brush’n'Save”的英文版现已面向全球130个国家和地区发布。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
CellProthera宣布领导人更替
法国米卢斯 (美国商业资讯) — CellProthera是一家提供市面上最先进的用于心肌梗塞后心肌损伤再生的细胞治疗药物的公司，该公司宣布领导人更替，任命Matthieu de Kalbermatten为首席执行官。他接替了Jean-Claude Jelsch（监事会现任主席）的职位，目前与公司董事长Philippe Hénon教授一起掌管这家生物技术公司。...
View ArticleClik here to view.
セルプロセラの新しいガバナンスを発表
仏ミュルーズ 心筋梗塞で障害を受けた心筋を再生するための最も高度な細胞療法製品を提供するセルプロセラは、コーポレートガバナンスを変更して、Matthieu de Kalbermattenを最高経営責任者（CEO）に任命しました。KalbermattenはJean-Claude Jelsch（現監査役会長）の後任となり、会長のPhilippe...
View ArticleClik here to view.
MPEG LA宣布推出计划以满足CRISPR许可需求
丹佛 (美国商业资讯)–技术许可领域的世界领导者MPEG LA, LLC今日宣布推出一项计划，以满足市场对高效一站式CRISPR许可替代方案的需求，CRISPR是一项突破性技术，支持快速、廉价地编辑细胞DNA。一些CRISPR专利目前成为多个专利持有人和申请人的专利抵触程序（106048号）的主体，而交由美国专利商标局调查。 MPEG LA总裁兼首席执行官Larry...
View Article